Phase 2 Advanced Osteosarcoma Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 2

Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study

Metastatic OsteosarcomaRecurrent OsteosarcomaRefractory Osteosarcoma+2 more

M.D. Anderson Cancer Center40 enrolled2 locationsNCT05019703

Recruiting

Phase 1Phase 2

Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma

Advanced Renal Cell CarcinomaAdvanced MesotheliomaAdvanced Osteosarcoma

M.D. Anderson Cancer Center50 enrolled1 locationNCT05703854

Completed

Phase 2

Cancer Molecular Screening and Therapeutics (MoST) Program Substudy Addendum 11 substudy 25-26: Tildrakizumab

Soft Tissue SarcomaCancerAdvanced Osteosarcoma

The University of Sydney32 enrolled8 locationsACTRN12620000984998